Back

PDK1: one abbreviation, two kinases, relentless confusion

Kociper, B.; Mis, K.; Garcia-Roves, P. M.; Chibalin, A. V.; Rustan, A. C.; Gnaiger, E.; Pirkmajer, S.

2025-12-03 biochemistry
10.64898/2025.12.01.691077 bioRxiv
Show abstract

The abbreviation PDK1 may refer to two different proteins: pyruvate dehydrogenase kinase 1 and 3-phosphoinositide-dependent protein kinase 1. This overlap introduces ambiguity, making it challenging to discern which protein is being referenced. Here, we highlight widespread confusion surrounding PDK1, including cases where articles have stated incorrect antibodies, referred to incorrect sequences for PCR, gene silencing, or plasmid construction, merged the properties of pyruvate dehydrogenase kinase 1 and 3-phosphoinositide-dependent protein kinase 1, or incorrectly cited the other protein. Notably, 19 % of articles with the term "PDK1" on PubMed, published between 2019 and the middle of 2025, contain at least one such mistake. This ambiguity extends beyond the scientific literature to websites of biotechnology providers and vendors, where antibodies or recombinant proteins are misattributed. To mitigate this issue, the use of unique protein abbreviations, clear antibody and sequence identification, and a more rigorous peer review process are needed.

Matching journals

The top 12 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.